Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGF β‐induced epithelial‐to‐mesenchymal transition

Dysregulated epithelial to mesenchymal transition (EMT) in cancer cells endows invasive and metastatic properties upon cancer cells that favor successful colonization of distal target organs and therefore play a critical role in transforming early‐stage carcinomas into invasive malignancies. EMT has also been associated with tumor recurrence and drug resistance and cancer stem cell initiation. Therefore, better understanding of the mechanisms behind EMT could ultimately contribute to the development of novel prognostic approaches and individualized therapies that specifically target EMT processes. As an effort to characterize the central transcriptome changes during EMT, we have developed a Transforming growth factor (TGF)‐beta‐based in vitro EMT model and used it to profile EMT‐related gene transcriptional changes in two different cell lines, a non‐small cell lung cancer cell line H358, and a breast cell line MCF10a. After 7 days of TGF‐beta/Oncostatin M (OSM) treatment, changes in cell morphology to a mesenchymal phenotype were observed as well as concordant EMT‐associated changes in mRNA and protein expression. Further, increased motility was noted and flow cytometry confirmed enrichment in cancer stem cell‐like populations. Microarray‐based differential expression analysis identified an EMT‐associated gene expression signature which was confirmed by RT‐qPCR and which significantly overlapped with a previously published EMT core signature. Finally, two novel EMT‐regulating transcription factors, IRF5 and LMCD1, were identified and independently validated.

[1]  Bo Ram Kim,et al.  BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation , 2015, Tumor Biology.

[2]  W. V. van IJcken,et al.  Endogenous WNT Signals Mediate BMP-Induced and Spontaneous Differentiation of Epiblast Stem Cells and Human Embryonic Stem Cells , 2014, Stem cell reports.

[3]  S. Koul,et al.  The transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells. , 2014, The Journal of Biological Chemistry.

[4]  N. Khuntikeo,et al.  BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma , 2014, Tumor Biology.

[5]  V. Findlay,et al.  Epithelial to mesenchymal transition and the cancer stem cell phenotype: Insights from cancer biology with therapeutic implications for colorectal cancer , 2014, Cancer Gene Therapy.

[6]  S. Bekiranov,et al.  Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition , 2013, Epigenetics & Chromatin.

[7]  A. Rosato,et al.  HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness , 2013, Oncotarget.

[8]  S. Wölfl,et al.  Bone morphogenetic protein‐9 induces epithelial to mesenchymal transition in hepatocellular carcinoma cells , 2013, Cancer science.

[9]  W Abou-Kheir,et al.  MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms , 2013, Oncogene.

[10]  Jeroen Krijgsveld,et al.  Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. , 2012, Cell reports.

[11]  B. J. Van den Eynde,et al.  Epithelial-Mesenchymal-Transition-Like and TGFβ Pathways Associated with Autochthonous Inflammatory Melanoma Development in Mice , 2012, PloS one.

[12]  Michael Peyton,et al.  An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.

[13]  H. Ditzel,et al.  Functional Heterogeneity within the CD44 High Human Breast Cancer Stem Cell-Like Compartment Reveals a Gene Signature Predictive of Distant Metastasis , 2012, Molecular medicine.

[14]  Y. Jou,et al.  Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma , 2012, Oncogene.

[15]  Liping Wei,et al.  Thrombin receptor regulates hematopoiesis and endothelial-to-hematopoietic transition. , 2012, Developmental cell.

[16]  Dimitris Anastassiou,et al.  Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo , 2011, BMC Cancer.

[17]  M. Hameed,et al.  Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis , 2011, Breast Cancer Research.

[18]  H. Lai,et al.  Abstract 3433: Disruption of TGF-β signaling induces demethylation of E-cadherin promoter and reverses mesenchymal phenotype in ovarian cancer , 2011 .

[19]  Jianxing He,et al.  Epithelial mesenchymal transition and lung cancer. , 2010, Journal of thoracic disease.

[20]  Kakajan Komurov,et al.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.

[21]  P. Jaakkola,et al.  Hypoxic conversion of SMAD7 function from an inhibitor into a promoter of cell invasion. , 2010, Cancer research.

[22]  A. Puisieux,et al.  TWISTing an embryonic transcription factor into an oncoprotein , 2010, Oncogene.

[23]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[24]  C. Arce,et al.  Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis , 2009, BMC proceedings.

[25]  Patricia Greninger,et al.  A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. , 2009, Cancer cell.

[26]  P. Leung,et al.  Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. , 2008, Molecular endocrinology.

[27]  Robert A. Weinberg,et al.  Twisted epithelial–mesenchymal transition blocks senescence , 2008, Nature Cell Biology.

[28]  Buzz Baum,et al.  Transitions between epithelial and mesenchymal states in development and disease. , 2008, Seminars in cell & developmental biology.

[29]  Kou-Juey Wu,et al.  Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.

[30]  J. Clements,et al.  Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.

[31]  Feng Chen,et al.  Smad7 Antagonizes Transforming Growth Factor β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation , 2007, Molecular and Cellular Biology.

[32]  K. Honda,et al.  Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression , 2007, Proceedings of the National Academy of Sciences.

[33]  Sheung Tat Fan,et al.  Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition , 2006, Clinical Cancer Research.

[34]  Barbara A. Murphy,et al.  Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma , 2006 .

[35]  M. Lu,et al.  LMCD1/Dyxin Is a Novel Transcriptional Cofactor That Restricts GATA6 Function by Inhibiting DNA Binding , 2005, Molecular and Cellular Biology.

[36]  M. Burmeister,et al.  Identification of a novel LIM domain gene, LMCD1, and chromosomal localization in human and mouse. , 2000, Genomics.